Rezzayo savings card: up to $400 off for 200 mg vial with commercial insurance

Rezzayo is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How to pay the least

Given by your care team

Billed by the clinic

Rezzayo is given by a doctor or nurse, not picked up at a pharmacy.

Ask your care team or your plan what you’d pay before your visit.

Compare every option

Brand nameRezzayo

Authorized genericrezafungin

Regular genericrezafungin

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldNone found

Same as Rezzayo?

The original

–

Brand nameThe maker’s card

REZZAYO Copay Savings Program

Savings card from Melinta Therapeutics

No insuranceNeeds insuranceNo cash price listed.

Insurance · up to $400 off for 200 mg vial

Or call 1-866-739-9296.

In the maker’s words

“Copay support for eligible patients with private for REZZAYO™ commercial insurance Up to $400 per 200 mg vial…”

From the maker’s offer on rezzayo.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Rezzayo itself, from the same company, sold without the brand name, and usually for less. For now Rezzayo is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

Serious yeast infections (Candida)

What the FDA label says

REZZAYO is an echinocandin antifungal indicated in adults and pediatric patients 12 years of age or older who have limited or no alternative options for the treatment of candidemia and invasive candidiasis. Approval of this indication is based on limited clinical safety and efficacy data for REZZAYO.

Limitations of Use REZZAYO has not been studied in patients with endocarditis, osteomyelitis, and meningitis due to Candida.

Source: the FDA label for Rezzayo (Melinta Therapeutics, LLC), July 1, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to the clinic’s billing office.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/rezzayo/